SCHEMBL3847718

SCHEMBL3847718

Fc1cccc(F)c1-c1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1-c1ccc2nc[nH]c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.46
QPCTL Q9NXS2 5/20 0.44
QPCT Q16769 5/20 0.44
ALOX5AP P20292 3/20 0.41
FEN1 P39748 3/20 0.41
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37
TGFBR1 P36897 3/20 0.37
TGFBR2 P37173 2/20 0.37
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PRKCI P41743 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAP3K20 Q9NYL2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847832 0.87 QPCT (0.45) QPCTLQPCTALOX5APFEN1ADORA2A
SCHEMBL3847721 0.82 MAPK14 (0.38) MAPK14QPCTLQPCTALOX5APFEN1
SCHEMBL3853393 0.75 MAPK14 (0.32) MAPK14ADORA1ALDH1A1
SCHEMBL3847529 0.75 CYP3A4 (0.40) TGFBR1KDM4EALDH1A1TP53HPGD
SCHEMBL3844886 0.75 MAP4K4 (0.36) TGFBR1ALDH1A1TP53CYP2D6
SCHEMBL3848884 0.74 EGFR (0.39) ALOX5APFEN1ALDH1A1CYP2D6
SCHEMBL3849190 0.74 TGFBR1 (0.44) ADORA2AADORA2BADORA1TGFBR1TGFBR2
SCHEMBL3856088 0.73 MAPK14 (0.39) MAPK14
SCHEMBL3854592 0.73 FGFR1 (0.35) ALDH1A1
SCHEMBL3846896 0.73 CYP3A4 (0.36) TGFBR1KDM4EALDH1A1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed